LUND, Sweden, Oct. 7, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa” or the “Company”) (NASDAQ STOCKHOLM: HNSA), today announced positive results from a 12-month follow up analysis from the NICE-01 trial of HNSA-5487, the Company’s next […]
Tag: Hansa Biopharma AB
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
LUND, Sweden, Sept. 5, 2024 /PRNewswire/ — Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Analyst at H.C. Wainwright on Wednesday, […]
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
LUND, Sweden, Sept. 5, 2024 /PRNewswire/ — Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Analyst at H.C. Wainwright on Wednesday, […]
Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
LUND, Sweden, Aug. 23, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa” or the “Company”) (Nasdaq Stockholm: HNSA), today announced that Matthew Shaulis, Chief Commercial Officer and US President has decided to leave the company in […]
Hansa Biopharma Announces Departure of Chief Commercial Officer, Matthew Shaulis
LUND, Sweden, Aug. 23, 2024 /PRNewswire/ — Hansa Biopharma AB, (“Hansa” or the “Company”) (Nasdaq Stockholm: HNSA), today announced that Matthew Shaulis, Chief Commercial Officer and US President has decided to leave the company in […]